[CHICAGO] Johnson & Johnson on Wednesday kicked off a final 60,000-person trial of a single-shot Covid-19 vaccine that potentially would simplify distribution of millions of doses compared...

[FRANKFURT] Buyout group Permira has agreed to buy German pharma group Neuraxpharm as it seeks to benefit from an expected surge in demand for the company's antidepressants, painkillers and other...

[BENGALURU] Gene sequencing company Illumina Inc will pay US$7.1 billion in cash and stock to buy cancer test startup Grail, the Wall Street Journal reported on Monday, citing people familiar with...

[BENGALURU] The European Medicines Agency (EMA) has recommended approval for Lynparza in patients with a form of prostate cancer and as a first-line maintenance treatment for a form of advanced...

SINCE joining Singapore Exchange (SGX)-listed specialty pharmaceutical company iX Biopharma, Janakan Krishnarajah has been getting involved in many new aspects of the drug making business.

[TOKYO] Takeda Pharmaceutical said on Wednesday it would sell its TachoSil surgical patch product to Corza Health for 350 million euros (S$563.7 million) as the Japanese company continues to...

[NEW YORK] Eastman Kodak, seeking to address the firestorm of allegations surrounding a Trump administration loan, said it mishandled the process of awarding stock option grants to its chief...

COVID-19 has been the rudest wake-up call to the importance of biomedical research. One in 200 diseases known to science have meaningful treatments, while drug candidates face a 10,000-to-one odds...

[NEW JERSEY]  Merck plans to take an equity stake and pay as much as US$4.5 billion in a series of deals with Seattle Genetics for two of its cancer drugs.

[BENGALURU] Gilead Sciences will acquire biopharmaceutical company Immunomedics for US$21 billion, a move that will strengthen its cancer portfolio by gaining access to a promising drug, the two...